Peptide Therapy Made Simple.

Bringing modern metabolic medicine directly to you.

SCHEDULE A MEDICAL EVALUATION

Access to Care Wherever You Are

Where We Offer Virtual Care

Your Personalized Care Journey

Every plan begins with a comprehensive medical evaluation, provider review, and coordinated ongoing care.

📅

Step 01: Schedule Your Consultation

Meet with a licensed provider to discuss your goals, ask questions, and explore available metabolic and regenerative care options.

📝

Step 02: Complete a Health Intake

Submit your secure medical history and symptom profile for comprehensive clinical evaluation.

📋

Step 03: Provider Review

Your provider reviews your intake and determines an individualized care plan based on your history, goals, and overall health picture.

🤝

Step 04: Care Coordination

If treatment is indicated, prescriptions are coordinated and progress is monitored to ensure safety and effectiveness.

Schedule Your Medical Evaluation

Nationwide Virtual Care Access

Receive modern metabolic care and peptide therapies from the comfort of home — available in nearly every U.S. state.

SHAYANN SCOTT THERAPEUTICS™ coordinates access to care in 48 U.S. states through a licensed telehealth network. Virtual consultations are currently unavailable in Alabama and Mississippi due to state-specific regulations.

• Secure, HIPAA-compliant telehealth visits conducted through video.
• Provider-supervised treatment plans tailored to your health goals.
• Ongoing follow-ups, progress monitoring, and personalized care coordination.
• Prescriptions issued by licensed clinicians when medically appropriate.

In-Person Care in Arizona

Prefer an in-person visit? Our Chandler, Arizona location inside SHAYANN SCOTT THERAPEUTICS™ offers hands-on therapies, functional wellness consultations, and local support that complements your telehealth care plan.

Services are provided under licensed clinician supervision and follow all applicable telehealth regulations. All visits are HIPAA-compliant and conducted through secure platforms.